Home/Pipeline/IL-2 Efficacy Program

IL-2 Efficacy Program

Oncology Supportive Care

ResearchActive

Key Facts

Indication
Oncology Supportive Care
Phase
Research
Status
Active
Company

About Aelan Cell Technologies

Aelan Cell Technologies is a private, pre-revenue biotech firm developing a novel platform to harness the therapeutic potential of adult stem cells, which it conceptualizes as a 'pharmacy' of natural regenerative factors. Its pipeline includes programs in regenerative medicine for post-cancer treatment recovery, a diagnostic biomarker for Alzheimer's disease, and personalized anti-aging cosmetics. The company is building its intellectual property portfolio and has established key research collaborations with institutions like the Buck Institute and the Gladstone Institute to advance its technologies.

View full company profile

Other Oncology Supportive Care Drugs

DrugCompanyPhase
Biosimilar Candidate BChina Resources Pharmaceutical GroupPhase I / Phase II